Dare Bioscience Inc (DARE)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current DARE market cap is 23.45M. The company's latest EPS is USD -0.4581 and P/E is -5.89.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.81M | 9k | 23k | 41k | -64k |
| Operating Income | -5.17M | -6.02M | -7.36M | -4.69M | -5.39M |
| Net Income | -5.06M | -6.76M | 12.91M | -4.7M | -5.51M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 10M | 2.81M | 9k |
| Operating Income | -27.4M | -39.07M | -31.39M | -30.94M | -23.45M |
| Net Income | -27.4M | -38.7M | -30.95M | -30.16M | -4.05M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.28M | 13.01M | 23.61M | 18.06M | 22.1M |
| Total Liabilities | 26.33M | 24.01M | 20.94M | 19.54M | 28.11M |
| Total Equity | -5.05M | -11M | 2.67M | -1.48M | -6.01M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.55M | 55.81M | 43.83M | 21.28M | 22.1M |
| Total Liabilities | 8.7M | 17.05M | 32.71M | 26.33M | 28.11M |
| Total Equity | -1.15M | 38.75M | 11.11M | -5.05M | -6.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -38.86M | -6.81M | 6.09M | 168k | 5.39M |
| Investing | -629k | -7k | -293k | -10k | -573k |
| Financing | 15.64M | 14k | 129k | 566k | 434k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.24M | -28.76M | -18.09M | -38.86M | 5.39M |
| Investing | -18k | -15k | -63k | -629k | -573k |
| Financing | 25.13M | 75.85M | 1.34M | 15.64M | 434k |
| Market Cap | 23.45M |
| Price to Earnings Ratio | -5.89 |
| Price to Sales Ratio | 2.7k |
| Price to Cash Ratio | 1.52 |
| Price to Book Ratio | -3.97 |
| Dividend Yield | - |
| Shares Outstanding | 8.85M |
| Average Volume (1 week) | 61.65k |
| Average Volume (1 Month) | 39.28k |
| 52 Week Change | -49.70% |
| 52 Week High | 5.76 |
| 52 Week Low | 2.56 |
| Spread (Intraday) | 0.04 (1.49%) |
| Company Name | Dare Bioscience Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.darebioscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
